Increases in Levels of Schistosome‐Specific Immunoglobulin E and CD23+B Cells in a Cohort of Kenyan Children Undergoing Repeated Treatment and Reinfection withSchistosoma mansoni
Author(s) -
Carla L. Black,
Erick M. O. Muok,
Pauline N. M. Mwinzi,
Jennifer M. Carter,
Diana M. S. Karanja,
W. Evan Secor,
Daniel G. Colley
Publication year - 2010
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/653828
Subject(s) - praziquantel , schistosoma mansoni , schistosomiasis , immunology , immunoglobulin e , cd23 , helminthiasis , antibody , immune system , biology , medicine , helminths
Age prevalence curves for areas in which schistosomiasis is endemic suggest that humans develop partial immunity to reinfection beginning in early adolescence. We conducted a 2-year longitudinal study to determine whether children infected with Schistosoma mansoni develop protection-related immune responses after treatment with praziquantel and whether the development of these immune responses is accelerated by frequent treatment after reinfection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom